|
International News Sending AIDS Drugs to Haitians in Need Is Massachusetts Institute of Technology Student's ProjectMarch 14, 2002 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! For the past year, Sanjay Basu, a 21-year-old neuroscience major at Massachusetts Institute of Technology (MIT) has transformed his tiny dorm room into a non-profit prescription-drug-transfer center, where he collects and then sends thousands of doses of AIDS medicines to a clinic in Haiti. Between classes, the senior is building a network of pharmacists who send him express packages of unused AIDS drugs, sometimes secretly. So far, he has recruited 26 in 18 states. They send him drugs that were returned from drug-resistant patients, or because side effects caused a patient to switch medications. Sometimes, family members send pills after a patient dies. Many states forbid redispensing drugs, primarily for safety and liability reasons. Some drug makers pay companies to collect and incinerate returned and expired drugs. Doctors and pharmacy administrators say that millions of doses are thrown away every year. But a few pharmacists ignore the laws and hand over returned AIDS medicines to groups ministering to the sick and dying. "The medicines pile up and they get near their expiration date and I just can't bear to destroy them," said one pharmacist, anonymously. Basu's enterprise is gathering its supplies pill by pill -- 10,000 pills so far. The US Food and Drug Administration says the federal Prescription Drug Marketing Act, with some exceptions, calls for distributors of medicines to be licensed by the state, which Basu is not. Wall Street Journal 03.14.02; Rachel Zimmerman A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|